Equibles does not estimate personal net worth.
Get an email with a short summary when Baxter International Inc publishes a filing, an earnings call transcript or a press release.
Get BAX alertsJosé Almeida is recorded as CEO at Baxter International Inc (BAX). The newest filing on record that lists José Almeida as CEO at Baxter International Inc (BAX) is dated March 23, 2026. The proxy statement of Baxter International Inc reports total compensation of $7,666,044 for José Almeida in fiscal 2025, including a base salary of $660,420. Disclosed compensation is on record for 9 fiscal years. José Almeida has spoken on 7 earnings calls across 1 company, most recently for Baxter International Inc on May 2, 2024. Baxter International Inc is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Baxter International Inc includes Andrew Hider (CEO, CFO and Board Member), Brent Shafer (CEO and Chairman), Anita Zielinski (CFO and Chief Accounting Officer) and 7 others.
“We appreciate you taking the time to join us today. I will begin with an overview of our first quarter results and then provide some updates regarding our ongoing strategic transformation.”
“We appreciate you taking the time to join us. I will begin with a brief overview of Baxter’s performance for the quarter and the year. After this, I will review our progress against the transformational actions we laid out for you just over a year ago, including the planned separation of our Kidney Care business.”
“I will begin with an overview of Baxter's second quarter 2023 performance followed by a look at the progress we're making across the strategic actions we announced earlier this year.”
“We appreciate you taking the time to join today's call. I will begin with an overview of our first quarter performance and trajectory. Jay will follow with a closer look at our financials as well as our outlook for Q2 and the remainder of 2023.”
“We appreciate you taking the time to join us. I will begin with a brief overview of Baxter's performance for the quarter and year and then provide some additional information on the strategic roadmap we announced on January 6.”
Start not stated–present
Last confirmed March 23, 2026
Medical Instruments & Supplies · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Baxter International Inc (BAX) | Former Chair of the Board, President and CEO | $660,420 | $7,666,044 |
| 2024 | Baxter International Inc (BAX) | Former Chair of the Board, President and Chief Executive Officer | $1,300,000 | $18,071,015 |
| 2023 | Baxter International Inc (BAX) | Former Chair of the Board, President and Chief Executive Officer | $1,300,000 | $13,786,671 |
| 2022 | Baxter International Inc (BAX) | Former Chair of the Board, President and Chief Executive Officer | $1,300,000 | $13,588,236 |
| 2021 | Baxter International Inc (BAX) | Chair of the Board, President and Chief Executive Officer | $1,300,000 | $15,634,734 |
| 2020 | Baxter International Inc (BAX) | Chair, President and Chief Executive Officer | $1,300,000 | $15,865,396 |
| 2019 | Baxter International Inc (BAX) | Chairman of the Board, President and Chief Executive Officer | $1,300,000 | $13,913,821 |
| 2018 | Baxter International Inc (BAX) | Chairman of the Board, Chief Executive Officer and President | $1,300,000 | $15,645,125 |
| 2017 | Baxter International Inc (BAX) | Chairman of the Board, Chief Executive Officer and President | $1,300,000 | $14,933,664 |
